๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Bortezomib in combination with IGEV chemotherapy regimen for a primary refractory Hodgkin's lymphoma of bone

โœ Scribed by Li Ding; Heng-Xiang Wang; Mei Xue; Ling Zhu; Jing Liu; Hong-Min Yan; Lian-Ning Duan; Zhi-Dong Wang

Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
662 KB
Volume
33
Category
Article
ISSN
0145-2126

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Etoposide, ifosfamide and methotrexate c
Etoposide, ifosfamide and methotrexate combination chemotherapy in patients with aggressive non-hodgkin's lymphoma after failure of the LNH 84 regimen
โœ R. Herbrecht; S. Ortiz; J. C. Damonte; K. L. Liu; F. Maloisel; P. Dufour; J. P. ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 353 KB

We assessed the efficacy of an etoposide, ifosfamide and methotrexate combination therapy (VIM) in 24 patients failing the LNH 84 protocol. Eight of these patients were refractory to the LNH 84 induction regimen, 10 were partial responders and the six remaining attained complete response after LNH 8

Salvage chemotherapy for non Hodgkin's l
Salvage chemotherapy for non Hodgkin's lymphoma of unfavourable histology with a combination of ccnu and vinblastine
โœ Dr. G. Palmieri; R. Lauria; F. Caponigro; C. Pagliarulo; V. Montesarchio; F. Nuz ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 309 KB

Twenty patients with relapsed or refractory, intermediate or high grade non Hodgkin's lymphoma were treated with a combination of CCNU and vinblastine. Complete responses occurred in four patients (20 per cent), partial responses in eight (40 per cent), for an overall response rate of 60 per cent. T

Improvement in complete response rate, d
Improvement in complete response rate, duration of response and survival with adriamycin combination chemotherapy for non-Hodgkin lymphoma: A prognostic factor comparison of two regimens
โœ Cabanillas, Fernando ;Rodriguez, Victorio ;Freireich, Emil J. ๐Ÿ“‚ Article ๐Ÿ“… 1978 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 509 KB

The results of a chemotherapy regimen utilizing adriamycin in combination with vincristine, prednisone plus or minus cyclophosphamide (CHOP-HOP) for the treatment of non-Hodgkin lymphoma are compared to those of a non-adriamycin containing combination (COP). The complete remission (CR) rate of 67% f